Neurosense Therapeutics Ltd.'s total assets for Q4 2022 were $7.71M, a decrease of -16.47% from the previous quarter. NRSN total liabilities were $2.09M for the fiscal quarter, a 51.08% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.